GSE196434
Transcriptional profiles of melanoma metastases from patients responsive or resistant to BRAF/MEK inhibitor
Transcriptional profiles of formalin-fixed-paraffin-embedded melanoma metastases including pre-treatment (PRE) and post-treatment (POST) specimens from 50 patients treated with BRAF inhibitors or with BRAF and MEK inhibitors Overall design: 91 samples from 50 patients showing a long-term response (LR) or a short-term response (SR) to treatment are included